Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05154669Phase 3Recruiting
Phase 3, randomised, open-label trial in Tobacco Use Disorder (TUD) (2 arms), sponsored by NYU Langone Health. Primary endpoints: Effectiveness of the integrated intervention to standard cessation counseling on long-term abstinence (salivary cotinine) at 12 months and Effectiveness of the integrated intervention to standard cessation counseling on long-term abstinence (CO concentration) at 12 months. Started Dec 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05154669.